SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000148
Filing Date
2023-08-08
Accepted
2023-08-08 07:15:43
Documents
14
Period of Report
2023-08-08
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230808.htm   iXBRL 8-K 33607
2 EX-99.1 a082023-atlas.htm EX-99.1 16643
6 image.jpg GRAPHIC 7489
  Complete submission text file 0001367644-23-000148.txt   198036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230808.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230808_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230808_pre.xml EX-101.PRE 13102
8 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230808_htm.xml XML 2923
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231149304
SIC: 2834 Pharmaceutical Preparations